The SpaceX IPO Could Be the Biggest in History. Here's What Investors Should Know Before It Lists

SpaceX has filed to go public on the Nasdaq under ticker SPCX, with reports suggesting a target valuation around $1.75 trillion to above $2 trillion and a potential $75 billion raise. The filing shows 2025 revenue of about $18.7 billion, but net loss of $4.9 billion, with Starlink generating 61% of revenue and roughly $4.4 billion in operating profit while the AI segment posted a $6.4 billion operating loss. The article argues the IPO may be heavily priced and highlights historical underperformance of mega-IPOs such as Saudi Aramco and Alibaba.

Analysis

The key issue is not whether SpaceX is a good company, but whether public-market buyers are being asked to underwrite a venture-style capital stack at a late-stage private-market price. If the IPO is near the reported range, the market is effectively paying for multiple future execution milestones simultaneously: Starlink monetization preservation, Starship commercialization, and a turnaround in the newly consolidated AI exposure. That creates a poor asymmetry because any one miss can compress the multiple materially, while the upside from “meeting expectations” is already largely embedded.

The second-order read-through is more interesting for public comparables than for the deal itself. A large, hyped listing that absorbs a major chunk of global risk capital can temporarily siphon attention and liquidity from adjacent high-beta growth names, especially those trading on optionality rather than current FCF. That environment tends to favor the already-profitable AI leader over narrative peers: capital rotates toward businesses with visible monetization and away from companies that still need several rounds of proof.

The clearest catalyst path is not the debut, but the first 1–2 quarters of post-listing disclosure. If Starlink subscriber growth remains strong while ARPU continues to slide, the market may start discounting the addressable-market story and focus more on unit economics. The real tail risk is execution on Starship and any impairment or restructuring associated with the AI segment; those are the kinds of items that can force a valuation reset months after the IPO, not on day one.

Contrarian view: the consensus may be underestimating how much private-market pricing discipline has already moved downstream into public comps. If the deal is intentionally priced to clear and creates a perceived scarcity asset, the immediate aftermarket could be tighter than skeptics expect. But that would likely be a trading event, not a durable setup, because the long-term holder still owns a business with one strong segment funding two unresolved ones.

Key Decisions for Investors

• Avoid chasing the IPO in the first print; wait for 1–2 quarterly reports post-listing before initiating any long exposure. Risk/reward is poor because the debut likely prices in several years of flawless execution.
• If given access, consider a short-dated put spread on SPCX after the first post-IPO lock-up/earnings window. The trade benefits from multiple compression if the market shifts from narrative to unit economics over the next 3–6 months.
• Overweight NVDA versus speculative AI beneficiaries for the next 1–2 quarters. In a capital-scarce tape, the market should continue rewarding current monetization and FCF rather than capital-intensive optionality.
• Use any IPO-driven weakness in BABA as a tactical long only if the stock de-rates on generalized growth/liquidity rotation rather than fundamentals. The setup is contrarian and should be sized as a mean-reversion trade with a 3–6 month horizon.
• For pairs, consider long NVDA / short a basket of pre-profit tech names if SPXC debuts at extreme valuation levels. That isolates quality-factor outperformance if the market becomes less tolerant of long-duration cash burn.